SIM
RVMD icon

Sandia Investment Management’s Revolution Medicines RVMD Stock Holding History

Sandia Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$398K Hold
5,000
– – 0.99% 38
2025
Q3 		$234K Hold
5,000
– – 0.7% 54
2025
Q2 		$184K Hold
5,000
– – 0.47% 65
2025
Q1 		$177K Hold
5,000
– – 0.52% 60
2024
Q4 		$219K Buy
+5,000
New +$252K 0.41% 62

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Sandia Investment Management's RVMD Position: Q4 2025 in Review

Sandia Investment Management held its Revolution Medicines (RVMD) position steady in Q4 2025 at 5,000 shares worth $398K. The position accounts for 0.99% of the portfolio, ranked #38.

Sandia Investment Management first reported a position in RVMD in Q4 2024 and has held it in 5 quarters since. 386 funds tracked by Wall St. Rank hold RVMD as of Q4 2025.

  • Sandia Investment Management held 5,000 shares of Revolution Medicines worth $398K as of Q4 2025.
  • Sandia Investment Management left its Revolution Medicines share count unchanged in Q4 2025.
  • Revolution Medicines made up 0.99% of Sandia Investment Management's portfolio in Q4 2025, its #38 holding.
  • Sandia Investment Management first reported a position in Revolution Medicines in Q4 2024 and has held it in 5 quarters since.
  • 386 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2025.

Based on Sandia Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.